Silence Therapeutics, Plc. earnings per share and revenue

SLNCF earnings per share for the last quarter are -0.09 USD whereas the estimation was -0.04 USD which accounts for -94.39% surprise. Company revenue for the same period amounts to 1.53 M USD despite the estimated figure of 5.85 M USD. Estimated earnings per share for the next quarter are -0.04 USD, and revenue is expected to reach 8.46 M USD. Also watch annual changes over time to get a bigger picture of SLNCF earnings per share and revenue dynamics.